Ozempic-class GLP-1 drugs linked to 30% lower breast cancer odds in study of 110,000 women - The Cool Down

Ozempic-class GLP-1 drugs linked to 30% lower breast cancer odds in study of 110,000 women - The Cool Down — OffsidePost